Clinical Trial Update: Efficacy and Safety of SOM3355 in Huntington's Disease Chorea [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting efficacy and safety of SOM3355 in Huntington's disease chorea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• SOM3355

Snippet

Sponsor: SOM Innovation Biotech SA | Conditions: Huntington's Chorea | Phase 2 | Status: COMPLETED